Key Challenges in Alzheimer’s Disease Gene Therapy Despite advances in target selection, delivery systems, and clinical strategies, Alzheimer’s disease (AD) gene therapy faces critical challenges: 1. Blood-Brain Barrier (BBB) and Delivery Efficiency Penetration Limits: The BBB blocks >95% of macr … Key Challenges in Alzheimer’s Disease Gene Therapy (2025 Assessment)Read more
Alzheimer’s Disease
Latest Advances in Alzheimer’s Disease Gene Therapy Clinical Trials
Latest Advances in Alzheimer’s Disease Gene Therapy Clinical Trials (2025 Update) Gene therapy for Alzheimer’s disease (AD) has achieved significant progress, with breakthroughs emerging across target selection, delivery technologies, and clinical strategies. Below is a systematic overview of recent … Latest Advances in Alzheimer’s Disease Gene Therapy Clinical TrialsRead more
Gene Therapy for Alzheimer’s Disease: Breakthroughs and Challenges
Gene Therapy for Alzheimer’s Disease: Breakthroughs and Challenges (As of May 2025) I. Core Therapeutic Strategies Alzheimer’s disease (AD) gene therapy focuses on modulating genetic risk factors, repairing neuronal damage, and inhibiting pathological protein accumulation (e.g., β-amyloid [Aβ] and t … Gene Therapy for Alzheimer’s Disease: Breakthroughs and ChallengesRead more